ΠŸΠΎΠΌΠΎΡ‰ΡŒ Π² написании студСнчСских Ρ€Π°Π±ΠΎΡ‚
АнтистрСссовый сСрвис

Π—Π°ΠΊΠ»ΡŽΡ‡Π΅Π½ΠΈΠ΅. 
Π‘Ρ‚Π²ΠΎΠ»ΠΎΠ²Ρ‹Π΅ ΠΊΠ»Π΅Ρ‚ΠΊΠΈ ΠΈ молСкулярная биология

Π Π΅Ρ„Π΅Ρ€Π°Ρ‚: Π—Π°ΠΊΠ»ΡŽΡ‡Π΅Π½ΠΈΠ΅. Π‘Ρ‚Π²ΠΎΠ»ΠΎΠ²Ρ‹Π΅ ΠΊΠ»Π΅Ρ‚ΠΊΠΈ ΠΈ молСкулярная биология
Π Π΅Ρ„Π΅Ρ€Π°Ρ‚ΠŸΠΎΠΌΠΎΡ‰ΡŒ Π² Π½Π°ΠΏΠΈΡΠ°Π½ΠΈΠΈΠ£Π·Π½Π°Ρ‚ΡŒ ΡΡ‚ΠΎΠΈΠΌΠΎΡΡ‚ΡŒΠΌΠΎΠ΅ΠΉ Ρ€Π°Π±ΠΎΡ‚Ρ‹

Davidson EH, Rast JP, Oliveri P, Ransick A, Calestani C, Yuh CH, Minokawa T, Amore G, Hinman V, Arenas-Mena C, Otim O, Brown CT, Livi CB, Lee PY, Revilla R, Rust AG, Pan Z, Schilstra MJ, Clarke PJ, Arnone MI, Rowen L, Cameron RA, McClay DR, Hood L, Bolouri H. A genomic regulatory network for development. Science. 2002 Mar 1;295(5560):1669βˆ’78. Cobbold SP, Nolan KF, Graca L, Castejon R, Le Moine A… Π§ΠΈΡ‚Π°Ρ‚ΡŒ Π΅Ρ‰Ρ‘ >

Π—Π°ΠΊΠ»ΡŽΡ‡Π΅Π½ΠΈΠ΅. Π‘Ρ‚Π²ΠΎΠ»ΠΎΠ²Ρ‹Π΅ ΠΊΠ»Π΅Ρ‚ΠΊΠΈ ΠΈ молСкулярная биология (Ρ€Π΅Ρ„Π΅Ρ€Π°Ρ‚, курсовая, Π΄ΠΈΠΏΠ»ΠΎΠΌ, ΠΊΠΎΠ½Ρ‚Ρ€ΠΎΠ»ΡŒΠ½Π°Ρ)

Π‘ ΠΏΠΎΠΌΠΎΡ‰ΡŒΡŽ молСкулярной Π±ΠΈΠΎΠ»ΠΎΠ³ΠΈΠΈ достигнут большой прогрСсс Π² ΠΏΠΎΠ½ΠΈΠΌΠ°Π½ΠΈΠΈ основных вопросов Π±ΠΈΠΎΠ»ΠΎΠ³ΠΈΠΈ стволовых ΠΊΠ»Π΅Ρ‚ΠΎΠΊ: самообновлСния ΠΈ Π΄ΠΈΡ„Ρ„Π΅Ρ€Π΅Π½Ρ†ΠΈΡ€ΠΎΠ²ΠΊΠΈ, Π° Ρ‚Π°ΠΊΠΆΠ΅ управлСния ΠΈΠΌΠΈ. Π‘Π»Π΅Π΄ΡƒΠ΅Ρ‚ ΠΎΡ‚ΠΌΠ΅Ρ‚ΠΈΡ‚ΡŒ, Ρ‡Ρ‚ΠΎ новСйшиС ΠΌΠ΅Ρ‚ΠΎΠ΄Ρ‹ молСкулярной Π±ΠΈΠΎΠ»ΠΎΠ³ΠΈΠΈ, Π½Π°ΠΏΡ€ΠΈΠΌΠ΅Ρ€, интСрфСрСнция РНК, сразу ΠΆΠ΅ находят ΠΏΡ€ΠΈΠΌΠ΅Π½Π΅Π½ΠΈΠ΅ Π² ΠΌΠΎΠ»Π΅ΠΊΡƒΠ»ΡΡ€Π½ΠΎΠΉ Π±ΠΈΠΎΠ»ΠΎΠ³ΠΈΠΈ стволовых ΠΊΠ»Π΅Ρ‚ΠΎΠΊ ΠΈ ΠΎΠΊΠ°Π·Ρ‹Π²Π°ΡŽΡ‚ся вСсьма ΠΏΡ€ΠΎΠ΄ΡƒΠΊΡ‚ΠΈΠ²Π½Ρ‹ΠΌΠΈ.

Π›ΠΈΡ‚Π΅Ρ€Π°Ρ‚ΡƒΡ€Π°

  • 1. Avots A, Harder F, Schmittwolf C, Petrovic S, Muller AM. Plasticity of hematopoietic stem cells and cellular memory. Immunol Rev. 2002;187:9−21
  • 2. Bapat SA, Mishra GC. Stem cell pharmacogenomics. Curr Top Med Chem. 2004;4(13):1371−83.
  • 3. Blechner MD, Mandavilli SR, Tsongalis GJ. Measuring telomerase activity for the early detection of cancer. Conn Med. 2001 ;65(11):643−8.
  • 4. Bunting KD, Hawley RG. Integrative molecular and developmental biology of adult stem cells. Biol Cell. 2003;95(9):563−78.
  • 5. Cavaleri F, Scholer HR. Nanog: a new recruit to the embryonic stem cell orchestra. Cell. 2003;113(5):551−2.
  • 6. Chambers I. The molecular basis of pluripotency in mouse embryonic stem cells. Cloning Stem Cells. 2004;6(4):386−91.
  • 7. Cobbold SP, Nolan KF, Graca L, Castejon R, Le Moine A, Frewin M, Humm S, Adams E, Thompson S, Zelenika D, Paterson A, Yates S, Fairchild PJ, Waldmann H. Regulatory T cells and dendritic cells in transplantation tolerance: molecular markers and mechanisms. Immunol Rev. 2003;196:109−24.
  • 8. Czyz J, Wobus A. Embryonic stem cell differentiation: the role of extracellular factors. Differentiation. 2001;68(4−5):167−74.
  • 9. Davidson EH, Rast JP, Oliveri P, Ransick A, Calestani C, Yuh CH, Minokawa T, Amore G, Hinman V, Arenas-Mena C, Otim O, Brown CT, Livi CB, Lee PY, Revilla R, Rust AG, Pan Z, Schilstra MJ, Clarke PJ, Arnone MI, Rowen L, Cameron RA, McClay DR, Hood L, Bolouri H. A genomic regulatory network for development. Science. 2002 Mar 1;295(5560):1669−78.
  • 10. Ducrest AL, Szutorisz H, Lingner J, Nabholz M. Regulation of the human telomerase reverse transcriptase gene. Oncogene. 2002 Jan 21;21(4):541−52.
  • 11. Era T. Bcr-Abl is a «molecular switch» for the decision for growth and differentiation in hematopoietic stem cells. Int J Hematol. 2002; 76(1):35−43.
  • 12. Faubert A, Lessard J, Sauvageau G. Are genetic determinants of asymmetric stem cell division active in hematopoietic stem cells? Oncogene. 2004 ;23(43):7247−55.
  • 13. Forsyth NR, Wright WE, Shay JW. Telomerase and differentiation in multicellular organisms: turn it off, turn it on, and turn it off again. Differentiation. 2002 Jan;69(4−5):188−97.
  • 14. Flickinger RA. Transcriptional frequency and cell determination. J Theor Biol. 2005;232(2):151−6.
  • 15. Hakelien AM, Collas P. Novel approaches to transdifferentiation. Cloning Stem Cells. 2002;4(4):379−87.
  • 16. Hande MP. DNA repair factors and telomere-chromosome integrity in mammalian cells. Cytogenet Genome Res. 2004;104(1−4):116−22.
  • 17. Hutchison CJ, Worman HJ. A-type lamins: guardians of the soma? Nat Cell Biol. 2004;6(11):1062−7.
  • 18. Jeanisch R, Eggan K, Humpherys D, Rideout W, Hochedlinger K. Nuclear cloning, stem cells, and genomic reprogramming. Cloning Stem Cells. 2002;4(4):389−96.
  • 19. Joshi C, Enver T. Molecular complexities of stem cells. Curr Opin Hematol. 2003;10(3):220−8.
  • 20. Kaminski N, Friedman N. Practical approaches to analyzing results of microarray experiments. Am J Respir Cell Mol Biol. 2002;27(2):125−32.
  • 21. Kassem M. Mesenchymal stem cells: biological characteristics and potential clinical applications. Cloning Stem Cells. 2004;6(4):369−74.
  • 22. Kassem M, Kristiansen M, Abdallah BM. Mesenchymal stem cells: cell biology and potential use in therapy. Basic Clin Pharmacol Toxicol. 2004;95(5):209−14.
  • 23. Larochelle A, Dunbar CE. Genetic manipulation of hematopoietic stem cells. Semin Hematol. 2004 ;41(4):257−71.
  • 24. Lessard J, Faubert A, Sauvageau G. Genetic programs regulating HSC specification, maintenance and expansion. Oncogene. 2004;23(43):7199−209.
  • 25. Liang Y, Van Zant G. Genetic control of stem-cell properties and stem cells in aging. Curr Opin Hematol. 2003 May;10(3):195−202.
  • 26. Lubbe J, Nakazawa H, Burg G. Telomerase. Hautarzt. 1997; 48(9):615−21.
  • 27. Martin-Rendon E, Watt SM. Exploitation of stem cell plasticity. Transfus Med. 2003;13(6):325−49.
  • 28. Musina RA, Egorov EE, Beliavskii AV. Stem cells: properties and perspectives of therapeutic use. Mol Biol. 2004;38(4):563−77.
  • 29. O’Neill A, Schaffer DV. The biology and engineering of stem-cell control. Biotechnol Appl Biochem. 2004;40(Pt 1):5−16.
  • 30. Pan GJ, Chang ZY, Scholer HR, Pei D. Stem cell pluripotency and transcription factor Oct4. Cell Res. 2002;12(5−6):321−9.
  • 31. Perez-Iratxeta C, Palidwor G, Porter CJ, Sanche NA, Huska MR, Suomela BP, Muro EM, Krzyzanowski PM, Hughes E, Campbell PA, Rudnicki MA, Andrade MA. Study of stem cell function using microarray experiments. FEBS Lett. 2005; 579(8):1795−801.
  • 32. Pomerantz J, Blau HM. Nuclear reprogramming: a key to stem cell function in regenerative medicine. Nat Cell Biol. 2004; 6(9):810−6.
  • 33. Rao RR, Stice SL. Gene expression profiling of embryonic stem cells leads to greater understanding of pluripotency and early developmental events. Biol Reprod. 2004;71(6):1772−8.
  • 34. Rasmussen TP. Embryonic stem cell differentiation: a chromatin perspective. Reprod Biol Endocrinol. 2003;1(1):100.
  • 35. Rizzino A. Embryonic stem cells provide a powerful and versatile model system. Vitam Horm. 2002;64:1−42.
  • 36. Robson P. The maturing of the human embryonic stem cell transcriptome profile. Trends Biotechnol. 2004;22(12):609−12.
  • 37. Ronnstrand L. Signal transduction via the stem cell factor receptor/c-Kit. Cell Mol Life Sci. 2004;61(19−20):2535−48.
  • 38. Sauvageau G, Iscove NN, Humphries RK. In vitro and in vivo expansion of hematopoietic stem cells. Oncogene. 2004;23(43):7223−32.
  • 39. Scherr M, Eder M. Modulation of gene expression by siRNA in hematopoietic cells. Curr Opin Drug Discov Devel. 2005;8(2):262−9.
  • 40. Scherr M, Steinmann D, Eder M. RNA interference (RNAi) in hematology. Ann Hematol. 2004 Jan;83(1):1−8.2003
  • 41. Shashikant CS, Ruddle FH. Impact of transgenic technologies on functional genomics. Curr Issues Mol Biol. 2003;5(3):75−98.
  • 42. Snoeck HW. Quantitative trait analysis in the investigation of function and aging of hematopoietic stem cells. Methods Mol Med. 2005;105:47−62.
  • 43. Stadtfeld M, Varas F, Graf T. Fluorescent protein-cell labeling and its application in time-lapse analysis of hematopoietic differentiation. Methods Mol Med. 2005;105:395−412.
  • 44. Steidl U, Kronenwett R, Martin S, Haas R. Molecular biology of hematopoietic stem cells. Vitam Horm. 2003;66:1−28.
  • 45. Stein MI, Zhu J, Emerson SG. Molecular pathways regulating the self-renewal of hematopoietic stem cells. Exp Hematol. 2004 ;32(12):1129−36.
  • 46. Stocum DL. Amphibian regeneration and stem cells. Curr Top Microbiol Immunol. 2004;280:1−70.
  • 47. Tzukerman M, Selig S, Skorecki K. Telomeres and telomerase in human health and disease. J Pediatr Endocrinol Metab. 2002; 15(3):229−40.
  • 48. Uher F, Hajdu M, Vas V. Self-renewal and differentiation of hematopoietic stem cells: a molecular approach (a review). Acta Microbiol Immunol Hung. 2003;50(1):3−21.
  • 49. Ulaner GA. Telomere maintenance in clinical medicine. Am J Med. 2004;117(4):262−9.
  • 50. Wall NR, Shi Y. Small RNA: can RNA interference be exploited for therapy? Lancet. 2003;362(9393):1401−3.
  • 51. Young HE, Duplaa C, Romero-Ramos M, Chesselet MF, Vourc’h P, Yost MJ, Ericson K, Terracio L, Asahara T, Masuda H, Tamura-Ninomiya S, Detmer K, Bray RA, Steele TA, Hixson D, el-Kalay M, Tobin BW, Russ RD, Horst MN, Floyd JA, Henson NL, Hawkins KC, Groom J, Parikh A, Blake L, Bland LJ, Thompson AJ, Kirincich A, Moreau C, Hudson J, Bowyer FP 3rd, Lin TJ, Black AC Jr. Adult reserve stem cells and their potential for tissue engineering. Cell Biochem Biophys. 2004;40(1):1−80.
  • 52. Zhu J, Emerson SG. Hematopoietic cytokines, transcription factors and lineage commitment. Oncogene. 2002;21(21):3295−313.
  • 53. Zou GM, Yoder MC. Application of RNA interference to study stem cell function: current status and future perspectives. Biol Cell. 2005; 97(3): 211−9.
  • 54. Zou GM, Yoder MC. Application of RNA interference to study stem cell function: current status and future perspectives. Biol Cell. 2005; 97(3): 211−9.
ΠŸΠΎΠΊΠ°Π·Π°Ρ‚ΡŒ вСсь тСкст
Π—Π°ΠΏΠΎΠ»Π½ΠΈΡ‚ΡŒ Ρ„ΠΎΡ€ΠΌΡƒ Ρ‚Π΅ΠΊΡƒΡ‰Π΅ΠΉ Ρ€Π°Π±ΠΎΡ‚ΠΎΠΉ

БСссия? Бпокойно!